首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   3607771篇
  免费   308038篇
  国内免费   14376篇
耳鼻咽喉   49381篇
儿科学   115327篇
妇产科学   94528篇
基础医学   572857篇
口腔科学   97729篇
临床医学   322320篇
内科学   650530篇
皮肤病学   95839篇
神经病学   310492篇
特种医学   139723篇
外国民族医学   490篇
外科学   552016篇
综合类   108121篇
现状与发展   24篇
一般理论   2367篇
预防医学   304459篇
眼科学   82539篇
药学   247946篇
  19篇
中国医学   11007篇
肿瘤学   172471篇
  2021年   56814篇
  2020年   35947篇
  2019年   59917篇
  2018年   74506篇
  2017年   56117篇
  2016年   61753篇
  2015年   75619篇
  2014年   110131篇
  2013年   175988篇
  2012年   106223篇
  2011年   107773篇
  2010年   121144篇
  2009年   124304篇
  2008年   92852篇
  2007年   97091篇
  2006年   106705篇
  2005年   101823篇
  2004年   102585篇
  2003年   92648篇
  2002年   81915篇
  2001年   120460篇
  2000年   114372篇
  1999年   109548篇
  1998年   66870篇
  1997年   64336篇
  1996年   62165篇
  1995年   57596篇
  1994年   51521篇
  1993年   48084篇
  1992年   74964篇
  1991年   70547篇
  1990年   66294篇
  1989年   64952篇
  1988年   59816篇
  1987年   58535篇
  1986年   55101篇
  1985年   54805篇
  1984年   49757篇
  1983年   45262篇
  1982年   42247篇
  1981年   39605篇
  1980年   37314篇
  1979年   40493篇
  1978年   35727篇
  1977年   32418篇
  1976年   29760篇
  1975年   28149篇
  1974年   29265篇
  1973年   28318篇
  1972年   26469篇
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
171.
172.
173.
174.

Objective

Comparative survival between neoadjuvant chemotherapy and adjuvant chemotherapy for patients with cT2-4N0-1M0 non–small cell lung cancer has not been extensively studied.

Methods

Patients with cT2-4N0-1M0 non–small cell lung cancer who received platinum-based chemotherapy were retrospectively identified. Exclusion criteria included stage IV disease, induction radiotherapy, and targeted therapy. The primary end point was disease-free survival. Secondary end points were overall survival, chemotherapy tolerance, and ability of Response Evaluation Criteria In Solid Tumors response to predict survival. Survival was estimated using the Kaplan–Meier method, compared using the log-rank test and Cox proportional hazards models, and stratified using matched pairs after propensity score matching.

Results

In total, 330 patients met the inclusion criteria (n = 92/group after propensity-score matching; median follow-up, 42 months). Five-year disease-free survival was 49% (95% confidence interval, 39-61) for neoadjuvant chemotherapy versus 48% (95% confidence interval, 38-61) for adjuvant chemotherapy (P = .70). On multivariable analysis, disease-free survival was not associated with neoadjuvant chemotherapy or adjuvant chemotherapy (hazard ratio, 1.1; 95% confidence interval, 0.64-1.90; P = .737), nor was overall survival (hazard ratio, 1.21; 95% confidence interval, 0.63-2.30; P = .572). The neoadjuvant chemotherapy group was more likely to receive full doses and cycles of chemotherapy (P = .014/0.005) and had fewer grade 3 or greater toxicities (P = .001). Response Evaluation Criteria In Solid Tumors response to neoadjuvant chemotherapy was associated with disease-free survival (P = .035); 15% of patients receiving neoadjuvant chemotherapy (14/92) had a major pathologic response.

Conclusions

Timing of chemotherapy, before or after surgery, is not associated with an improvement in overall or disease-free survival among patients with cT2-4N0-1M0 non–small cell lung cancer who undergo complete surgical resection.  相似文献   
175.
176.
177.
178.
Metabolism describes the series of chemical reactions that are concerned with the provision of energy to biological systems. They may be divided into reactions involved in energy yield (catabolism: demand exceeds supply), and energy storage (anabolism: supply exceeds demand). Regulation of these pathways is critical for homeostasis, and derangements in metabolism are seen in a wide variety of pathological processes. Understanding metabolism is key to the treatment of many diseases, notably diabetes, as well as underpinning clinical nutritional support.  相似文献   
179.
Chondrocytes are the main cells in the extracellular matrix (ECM) of articular cartilage and possess a highly differentiated phenotype that is the hallmark of the unique physiological functions of this specialised load-bearing connective tissue. The plasma membrane of articular chondrocytes contains a rich and diverse complement of membrane proteins, known as the membranome, which defines the cell surface phenotype of the cells. The membranome is a key target of pharmacological agents and is important for chondrocyte function. It includes channels, transporters, enzymes, receptors, and anchors for intracellular, cytoskeletal and ECM proteins and other macromolecular complexes. The chondrocyte channelome is a sub-compartment of the membranome and includes a complete set of ion channels and porins expressed in these cells. Many of these are multi-functional proteins with “moonlighting” roles, serving as channels, receptors and signalling components of larger molecular assemblies. The aim of this review is to summarise our current knowledge of the fundamental aspects of the chondrocyte channelome, discuss its relevance to cartilage biology and highlight its possible role in the pathogenesis of osteoarthritis (OA). Excessive and inappropriate mechanical loads, an inflammatory micro-environment, alternative splicing of channel components or accumulation of basic calcium phosphate crystals can result in an altered chondrocyte channelome impairing its function. Alterations in Ca2+ signalling may lead to defective synthesis of ECM macromolecules and aggravated catabolic responses in chondrocytes, which is an important and relatively unexplored aspect of the complex and poorly understood mechanism of OA development.  相似文献   
180.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号